Jill A. Howe - Chief Financial Officer at Lineage Cell Therapeutics, Inc.

Issuer-level insider activity

Role: Chief Financial Officer
Issuer ticker: LCTX on NYSE
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Jill A. Howe since 04 Oct 2025

Reported holdings for Jill A. Howe in Lineage Cell Therapeutics, Inc.

Form 4 holding Chief Financial Officer

Lineage Cell Therapeutics, Inc.

Security class: Employee Stock Option (Right to Buy)
Shares / value: 1,050,000
Estimated value
Report date: 05 Mar 2026
Price
Ownership: Direct
Underlying class: Common Shares
Underlying amount

Transaction history for Jill A. Howe in Lineage Cell Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .